As of 2026-03-24, the Relative Valuation of Charles River Laboratories International Inc (CRL) is (39.79) USD. This relative valuation is based on P/E multiples. With the latest stock price at 158.00 USD, the upside of Charles River Laboratories International Inc based on Relative Valuation is -125.2%.
The range of the Relative Valuation is (74.65) - 18.63 USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 25.5x - 33.6x | 31.0x |
| Forward P/E multiples | 16.5x - 35.6x | 21.4x |
| Fair Price | (74.65) - 18.63 | (39.79) |
| Upside | -147.2% - -88.2% | -125.2% |
| Date | P/E |
| 2026-03-23 | -53.89 |
| 2026-03-20 | -52.39 |
| 2026-03-19 | -52.20 |
| 2026-03-18 | -53.59 |
| 2026-03-17 | -52.43 |
| 2026-03-16 | -51.83 |
| 2026-03-13 | -53.02 |
| 2026-03-12 | -52.07 |
| 2026-03-11 | -57.61 |
| 2026-03-10 | -57.09 |
| 2026-03-09 | -60.37 |
| 2026-03-06 | -59.50 |
| 2026-03-05 | -61.84 |
| 2026-03-04 | -61.25 |
| 2026-03-03 | -59.92 |
| 2026-03-02 | -60.92 |
| 2026-02-27 | -60.88 |
| 2026-02-26 | -59.84 |
| 2026-02-25 | -57.15 |
| 2026-02-24 | -56.64 |
| 2026-02-23 | -55.77 |
| 2026-02-20 | -57.61 |
| 2026-02-19 | -56.02 |
| 2026-02-18 | -53.89 |
| 2026-02-17 | -54.07 |
| 2026-02-13 | -55.03 |
| 2026-02-12 | -54.14 |
| 2026-02-11 | -56.61 |
| 2026-02-10 | -61.82 |
| 2026-02-09 | -63.34 |
| 2026-02-06 | -64.53 |
| 2026-02-05 | -62.66 |
| 2026-02-04 | -68.77 |
| 2026-02-03 | -68.70 |
| 2026-02-02 | -72.72 |
| 2026-01-30 | -71.79 |
| 2026-01-29 | -72.20 |
| 2026-01-28 | -73.97 |
| 2026-01-27 | -74.88 |
| 2026-01-26 | -75.84 |
| 2026-01-23 | -74.90 |
| 2026-01-22 | -76.41 |
| 2026-01-21 | -77.35 |
| 2026-01-20 | -74.42 |
| 2026-01-16 | -74.93 |
| 2026-01-15 | -76.22 |
| 2026-01-14 | -73.81 |
| 2026-01-13 | -74.69 |
| 2026-01-12 | -74.63 |
| 2026-01-09 | -75.35 |